Delivery Order SPE2DB20D2014-SPE2DB25FC73Y
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for Eliquis 5 mg tablets (60-count units) valued at $7,758.02 by the Defense Logistics Agency. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 8, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a firm fixed-price delivery order valued at $95,223.63 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count units). The contract, awarded August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive, open-market award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $12,049.99 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 26, 2025. The award was issued on August 25, 2025, with no set-aside designation applied. This delivery order is a child contract executed under AmerisourceBergen's...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets in quantities of 60s, with a ceiling value of $12,825.81. The contract is classified as a Firm Fixed Price delivery order with an ultimate completion date of September 5, 2025, and was competitively awarded without a set-aside designation. The product will be sourced from the vendor's corporate office location in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,698.09 by the Defense Logistics Agency on July 31, 2025, for the supply of Eliquis 5 mg tablets (60-count). The award utilizes a firm fixed-price contract structure with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,311.84 by the Defense Logistics Agency (DLA) on April 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units). The contract, which is not set-aside, utilizes firm fixed pricing and carries an ultimate completion date of May 1, 2025. Performance of this order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under a larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for 60 tablets of Eliquis 5 mg at a ceiling value of $20,974.50. This competitively awarded, non-set-aside contract was executed on September 5, 2025, with an ultimate completion date of September 8, 2025. The firm fixed price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 9, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract ceiling value of $21,441.91. This firm fixed-price delivery order, which is not set-aside, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 12, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 2.5 mg tablets in a 60-count package configuration. This firm fixed-price delivery order carries a ceiling value of $3,931.20 and is scheduled for completion by September 15, 2025. The award was made through open competition with no set-aside designation and represents a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $6,803.26. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 19, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC73YDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Eliquis 5 mg tablets (60-count) with a ceiling value of $26,140.92. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price procurement with no set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The award demonstrates AmerisourceBergen's ongoing role as a critical vendor within the federal medical procurement supply chain, particularly for the Defense Health Agency and other military healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management, the company has consistently met federal procurement requirements through competitive award processes. The delivery order for Eliquis, an anticoagulant medication, reflects the company's established capability to fulfill therapeutic pharmaceutical needs across multiple clinical domains for federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.1k | 8/13/25 |